GKB logo

GKB Ophthalmics LTD.

GKB·BSE·
₹67.40▲ +3.39 (+5.30%)
Market Cap32.08 Cr
PE Ratio27.85
Volume34
Day High - Low67.46 - 64.01
52W High-Low76.02 - 58.25

Gkb Ophthalmics Ltd. (GKB): company summary

The company's business has improved significantly, with annual revenue rising 36.8% to ₹149 crore and net profit swinging from a loss of ₹7 crore to a profit of ₹3 crore.

Gkb Ophthalmics Ltd. (GKB) is a micro-cap Healthcare company valued at ₹32 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move
Gkb Ophthalmics Ltd. last traded at ₹67.4, sharply up 5.30% on the day.
Recent developments
On 2026-09-30, promoter holding was reported at 51.15%, indicating no significant change in ownership. On 2026-06-30, the company reported a net profit of ₹2 crore for the latest quarter, marking a turnaround from a net loss in the same quarter the previous year.
Financial performance
The company's business has improved significantly, with annual revenue rising 36.8% to ₹149 crore and net profit swinging from a loss of ₹7 crore to a profit of ₹3 crore. However, the latest quarter showed revenue growth of only 2.3% compared to the same quarter a year earlier, while net profit swung from a loss of ₹1 crore to a profit of ₹2 crore.
Valuation multiples
The stock trades at 27.9 times earnings, broadly in line with the Healthcare median of 32.0, 0.62 times book value.
Things to watch
The stock is 15.9% below its 52-week high, and the company's net profit margin remains low at 2.0%. The return on equity is also low at 2.3%, suggesting limited profitability relative to equity.
Where it stands
GKB Ophthalmics Limited has shown strong revenue growth over the past three years, but its profitability remains limited. The latest quarter marked a significant improvement in net profit, but the stock is still far below its recent high. The company's return on equity and net profit margin indicate ongoing challenges in generating returns for shareholders.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
3.4/10
Poor
Fair Value
Sign in to see
ROE
2.31%
Weak
P/E
27.85x
Fair
Debt / Equity
0.22
Low
Industry
Healthcare
Medical Equipment & Supplies
Overall View
Poor

Price performance

Day₹64.01
₹67.46
52W₹58.25
₹76.02
DocStoX take

Supported by valuation (6.5), but held back by quality (0.8).

DocStoX score

Low confidence
3.4
/10
Poor
Quality
Weak
ROE 2.3%
Valuation
Fair
P/E 27.9×
Growth
Slow
Revenue +47.5% 5Y CAGR
Risk
Moderate
D/E 0.22
Momentum
Firm
51% of 52-week range

At a glance

Market Cap
₹32 Cr
52W High / Low
₹76 / ₹58
Dividend Yield
0.00%
Promoter Holding
51.15%
EPS (TTM)
₹2.42
Book Value
₹104.82

Key highlights

  • Revenue compounding 48% a year
  • Low leverage — D/E 0.22
  • Profit shrinking 14% a year
  • Loss-making in some of the last 5 years
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Medical Equipment & Supplies

GKB OPHTHALMICS LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.